Search clinical trials for: Dipeptidyl Peptidase IV inhibitors
Total 1743 results
-
Ain Shams UniversityCompletedDiabetes Mellitus, Type 1 | NASHEgypt
-
Ajou University School of MedicineDong-A ST Co., Ltd.Not yet recruitingCerebral Infarction | Dipeptidyl-Peptidase IV Inhibitors | Infarction, Brain
-
Ain Shams UniversityCompleted
-
Changhua Christian HospitalCompletedType 2 Diabetes Mellitus | Proteinuria
-
University of British ColumbiaTerminated
-
Attikon HospitalRecruiting
-
Mayo ClinicPatient-Centered Outcomes Research InstituteActive, not recruitingType 2 Diabetes | Cardiac DiseaseUnited States
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknown
-
University of British ColumbiaMerck Frosst Canada Ltd.Completed
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknownLiver TransplantationDenmark
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Mexico, United States, Estonia, Bulgaria, Latvia, Romania, Lithuania, Puerto Rico, Costa Rica
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Italy, United States, Germany, Canada, Puerto Rico
-
University of Sao Paulo General HospitalUniversity of Sao PauloCompletedDiabetes Type 2Brazil
-
Boehringer IngelheimCompleted
-
Stanley Dudrick's Memorial HospitalTerminated
-
Peking University People's HospitalPeking University First Hospital; Jiangsu Province Geriatric InstituteRecruitingDiabetes Mellitus, Type 2 | Severe Insulin Deficient DiabetesChina
-
The Catholic University of KoreaCompletedDiabetes MellitusKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Bulgaria, Czechia, Hungary, Poland, Russian Federation
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers UniversityActive, not recruiting
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
JW PharmaceuticalActive, not recruitingType 2 Diabetes MellitusKorea, Republic of
-
NovartisCompletedDiabetes Mellitus, Type 2Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2Japan
-
Novartis PharmaceuticalsCompletedDiabetes | Renal ImpairmentRussian Federation
-
NovartisCompletedDiabetes Mellitus, Type 2Japan
-
NovartisCompletedDiabetes Mellitus, Type 2Japan
-
NovartisCompleted
-
TakedaCompleted
-
MTI UniversityNational Institute of Diabetes and Endocrinology, EgyptRecruitingType 2 Diabetes MellitusEgypt
-
University Malaysia SarawakSarawak General HospitalCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
Medical University of ViennaCompleted
-
NovartisCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom, Belgium, Bulgaria, Spain, Slovakia, Germany, Finland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2Germany, United States
-
NovartisCompletedDiabetes Mellitus, Type 2
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Federal University of São PauloNovartisUnknownType 1 Diabetes | Autoimmune Diabetes | Insulin Dependent Diabetes | Juvenile Onset Diabetes MellitusBrazil
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
NovartisCompletedType 2 Diabetes MellitusGermany, Romania, Hungary, Belgium, Slovakia, Australia, India, Czech Republic, Guatemala, Hong Kong, United Kingdom